Medical Oncologist Visa Pathway to Australia: Complete 2026 Guide
Updated: 13 May 2026
Australia classifies medical oncologists under ANZSCO 253314. The Royal Australasian College of Physicians (RACP) conducts the specialist comparability assessment that the Medical Board of Australia relies on for specialist registration. The occupation is on the MLTSSL and CSOL, unlocking subclasses 189, 190, 491, 482, and 186. Typical 2026 salaries range AUD $280,000-$483,000 with senior consultants in Sydney averaging $447,747.
Quick Facts: Medical Oncologist Migration Pathway
| Detail | Information |
|---|---|
| ANZSCO Code | 253314 (Medical Oncologist) |
| Skill Level | 1 (Bachelor degree or higher plus completed specialist training) |
| Skills Assessment | MedBA via RACP comparability assessment |
| Occupation List | MLTSSL and CSOL |
| Visa Options | 189, 190, 491, 482, 186 |
| Demand Level | High — driven by population ageing and expansion of cancer services |
| Salary Range | AUD $280,000-$483,000 (SalaryExpert 2026) |
| Typical 189 Score | 70-85 points (lower than ICT; medical specialists clear earlier) |
| Key Challenge | RACP assessment plus chemotherapy credentialling at the appointing hospital |
Role Context in Australia
Medical oncologists in Australia treat solid-organ malignancies and haematological cancers with systemic therapy — chemotherapy, targeted therapy, immunotherapy, and hormonal treatment. The workforce concentrates in tertiary cancer centres: Peter MacCallum Cancer Centre in Melbourne, Chris O'Brien Lifehouse and Royal Prince Alfred in Sydney, Princess Alexandra Hospital in Brisbane, Royal Adelaide Hospital, and Sir Charles Gairdner Hospital in Perth. Regional cancer centres in Wollongong, Newcastle, Geelong, Townsville, and Bendigo all run consultant oncology services.
Private practice plays a meaningful role through Icon Cancer Centre (the largest private network), GenesisCare, and St Vincent's Private. Many consultants combine a public staff specialist appointment with private rooms or a chair in a private day infusion centre. Locum medical oncology pays around $2,500-$3,000 per day in regional shortage areas.
The Australian Institute of Health and Welfare projects 169,000 new cancer diagnoses for 2026, a 6% increase on 2023. The federal Australian Cancer Plan and state cancer agencies (Cancer Council, Cancer Australia) explicitly identify medical oncology workforce expansion as a strategic priority. Jobs and Skills Australia lists specialist physicians within its persistent shortage clusters.
ANZSCO Code 253314
ANZSCO 253314 covers practitioners who diagnose and treat cancer with systemic therapies. Typical duties include assessing patients referred from primary care and other specialties, ordering and interpreting tumour staging investigations, formulating treatment plans through multidisciplinary team meetings, prescribing and supervising chemotherapy, targeted therapy, and immunotherapy, managing treatment toxicities, and coordinating ongoing surveillance and palliation.
The code is distinct from 253915 Radiation Oncologist (RANZCR-assessed) and 253918 Haematologist (also RACP-assessed but a separate advanced training program). Applicants whose training spans haematology and medical oncology should confirm which code matches their primary clinical practice — the RACP submission must align with the chosen ANZSCO code.
Skills Assessment
Step 1: RACP Specialist Assessment
The RACP is the designated specialist medical college for medical oncology and conducts the comparability assessment for the Medical Board of Australia's Specialist Pathway.
Standard Specialist Assessment Pathway — applies to all overseas-trained medical oncologists. RACP compares overseas training, examinations, recent practice, and CPD against the Australian advanced training program in medical oncology. An interview is mandatory before the comparability decision. Outcomes are substantially comparable (up to 12 months peer review), partially comparable (up to 24 months supervised practice), or not comparable.
Accelerated Specialist Pathway — fast-track route restricted to substantially comparable applicants from the United Kingdom, Republic of Ireland, India, Hong Kong, and Sri Lanka. Note: medical oncology is not currently on the Accelerated pathway specialty list (the eligible specialties are Cardiology, Paediatric Cardiology, Gastroenterology, Geriatric Medicine, Nephrology, and Adult Rehabilitation Medicine). Medical oncologists must use the Standard pathway.
Costs (2026 RACP fees, GST inclusive):
- Initial application fee: AUD $1,096
- Assessment of comparability fee: AUD $6,184
- Annual workplace-based assessment fee (during peer review or top-up training): AUD $4,802
- Total realistic range: AUD $7,280-$16,884
Processing time: 4-6 months for Standard pathway from application to comparability decision.
Common rejection reasons: Insufficient recent specialist practice (RACP expects 12 months of FTE specialist work in the 36 months before application). Training programs without a dedicated medical oncology component — combined "internal medicine and oncology" or "haemato-oncology" programs are scrutinised for the volume of solid-tumour medical oncology training. Membership qualifications (MRCP, FRCP) without a structured advanced training certification.
Step 2: AHPRA Specialist Registration via MedBA
The Medical Board of Australia grants specialist registration in medical oncology after RACP issues the comparability decision. Initial limited or specialist registration fee is around AUD $1,065, plus the annual registration fee.
English language: IELTS Academic 7.0 in each band, OET grade B in each component, PTE Academic 65, or recognised exemption.
Hospital Chemotherapy Credentialling
Practical note: most appointing hospitals require Local Health Network chemotherapy credentialling on top of RACP and AHPRA. This is administrative rather than examinable but takes 2-4 weeks once references and prescribing history are documented. Plan for it.
Visa Pathways for Medical Oncologists
Subclass 482 — Skills in Demand Visa (Specialist Skills Stream)
The dominant first-arrival route. Medical oncologists comfortably exceed the Specialist Skills Income Threshold, so the Specialist Skills stream applies.
- Visa fee: AUD $3,210 (primary applicant)
- Specialist Skills Income Threshold (from 1 July 2026): AUD $146,717 — every consultant role clears this
- Duration: Up to 4 years
- Processing: Medium-term stream typically 4-8 months
Cancer centres and Local Health Networks usually hold standing sponsorship and process visa applications in parallel.
Subclass 186 — Employer Nomination Scheme
Permanent residency through employer sponsorship. The Direct Entry stream is available where AHPRA specialist registration is in place; Temporary Residence Transition applies after 2 years on 482.
- Visa fee: AUD $4,910
- Processing: Direct Entry 9-15 months; TRT stream 12-18 months
- Quirk: Peter MacCallum, Chris O'Brien Lifehouse, and other dedicated cancer centres routinely sponsor 186 directly for substantially comparable applicants
Subclass 189 — Skilled Independent Visa
Permanent residency on points alone, available because 253314 is on the MLTSSL.
- Visa fee: AUD $4,910
- Typical invitation score in 2026: 70-85 points
- Processing: 12-18 months
Subclass 190 — Skilled Nominated Visa
State nomination adds 5 points. Useful when a state cancer service has indicated commitment but employer sponsorship is not the preferred route.
- Visa fee: AUD $4,910
Subclass 491 — Skilled Work Regional Visa
Regional nomination adds 15 points. Strong route for applicants accepting a regional cancer centre appointment.
- Visa fee: AUD $4,910
- Reality: Regional cancer centres (Wollongong, Geelong, Townsville, Cairns, Mackay) actively recruit overseas and bundle relocation packages
Points Test Strategy
Most overseas-trained medical oncologists are in the 32-42 age bracket by the time specialist training and post-fellowship experience are complete. The points test for medical specialists is less competitive than ICT, so 70-85 points typically secures an invitation.
| Points Factor | Points | Notes |
|---|---|---|
| Age (33-39) | 25 | Most common bracket |
| Age (25-32) | 30 | Possible for fast-tracked trainees |
| Qualification (Master's or higher) | 15 | Specialist fellowship usually meets this |
| Doctorate (PhD) | 20 | Common in academic and clinical-trial oncology |
| English (Superior — 8.0+) | 20 | OET grade A or IELTS 8 all bands |
| English (Proficient — 7.0) | 10 | Standard medical entry |
| Overseas skilled experience (8+ years) | 15 | Most senior consultants reach this |
| Australian skilled experience (1-3 years) | 5 | After RACP-approved supervised practice |
| State Nomination (190) | 5 | |
| Regional (491) | 15 | |
| Partner skills | 5-10 | If partner has skilled occupation |
Realistic Scenarios
Scenario 1: UK-trained medical oncologist, age 37, CCT in Medical Oncology, 5 years post-CCT consultant experience, OET grade A
- Age 25 + qualification 15 + English 20 + experience 15 = 75 points
- Add 491 regional nomination: 90 points — straightforward invitation
Scenario 2: Indian medical oncologist, age 41, DM Medical Oncology, 12 years post-DM, OET grade B, partner skilled assessment positive
- Age 15 + qualification 15 + English 10 + experience 15 + partner 10 = 65 points
- Realistic route is 482 → 186 with employer sponsorship, not 189
State Nomination for Medical Oncologists
New South Wales
NSW Health employs medical oncologists across Local Health Networks; Chris O'Brien Lifehouse, Royal Prince Alfred, and Royal North Shore are flagship cancer services. NSW's 190 program prioritises healthcare and routinely nominates specialist physicians. Sydney's private oncology market through Icon and GenesisCare is the deepest in the country.
Victoria
Peter MacCallum Cancer Centre is Australia's only standalone public cancer hospital and a major employer of medical oncologists. Victoria's 2025-26 nomination program closed early to ROIs on 28 April 2026; health occupations remain prioritised on reopening. Victoria typically requests evidence of AHPRA specialist registration or clear pathway to it.
Queensland
Queensland Health and major regional cancer services (Townsville Hospital, Princess Alexandra Hospital, Mater) recruit medical oncologists. Queensland's 2025-26 program allocated 2,600 places across 190 and 491, with specialist physicians explicitly listed.
South Australia and Western Australia
Both states actively nominate medical oncologists for regional placements through SA Health rural networks and WA Country Health Service. The Kinghorn Cancer Centre model is being replicated in Perth and Adelaide, expanding the consultant footprint.
Tasmania
The Royal Hobart Hospital and Launceston General Hospital both run consultant medical oncology services and use the 491 program actively.
Salary and Employment Outlook
What Can You Expect to Earn?
| Role | Typical 2026 Salary Range |
|---|---|
| Entry-level consultant (1-3 years) | AUD $280,000-$330,000 (SalaryExpert 2026 average for early career) |
| Mid-career staff specialist | AUD $330,000-$420,000 |
| Senior consultant (8+ years) | AUD $420,000-$500,000 (SalaryExpert 2026 senior average $483,095) |
| Private oncologist (Icon, GenesisCare, private rooms) | AUD $450,000-$800,000+ |
| Locum medical oncologist | AUD $2,500-$3,000/day |
| Sydney average (all levels) | AUD $447,747 (SalaryExpert 2026) |
Total packages include 11.5% superannuation, professional development funding, motor vehicle allowance, and CME leave. Staff specialists typically have rights of private practice that materially increase total income through private consulting fees and bulk-billed Medicare items.
Highest-Paying Settings
- Private day infusion practice — high-volume chemotherapy delivery in suburban centres
- Clinical trial leadership — pharma-funded research generates session fees on top of base
- Dual public-private appointments — most common high-income structure
- Regional and remote locum work — daily rates exceed metropolitan equivalents
Tips for a Successful Application
1. Standard Pathway only — plan for 4-6 months
Medical oncology is not on the Accelerated Specialist Pathway. Every overseas-trained medical oncologist goes through the Standard pathway with its full 4-6 month timeline. Lodge the RACP application early — references and primary source verification through EPIC alone take several weeks.
2. Document chemotherapy prescribing volumes
The RACP interview probes recent clinical workload. Maintain a structured logbook of chemotherapy regimens prescribed, multidisciplinary team meetings attended, and clinical trials enrolled in the 36 months before application. Vague summaries do not satisfy the comparability assessment.
3. Distinguish medical oncology from haematology and palliative medicine clearly
Applicants whose practice has drifted toward haemato-oncology or palliative care should clarify which advanced training program their certification belongs to. RACP scrutinises overlap closely; matching ANZSCO 253314 requires demonstrable solid-tumour medical oncology training.
4. Get hospital chemotherapy credentialling started early
Many Local Health Networks will not allow prescribing until internal chemotherapy credentialling is complete. References from former chemotherapy supervisors and prescribing histories should be collated before arrival, not after.
5. OET grade A for the points swing
The 10-point difference between Proficient and Superior English is the largest single swing in the points test. OET grade A is achievable with structured preparation and pays dividends for both 189/190 and Australian medical workforce credibility.
Step-by-Step Migration Roadmap
- Confirm ANZSCO code 253314 — see the ANZSCO code finder
- Verify medical oncologist is on the 2026 SOL and CSOL
- Submit primary source verification of qualifications via ECFMG/EPIC
- Lodge RACP comparability application (Standard pathway only)
- Sit OET or IELTS Academic — aim for OET grade A
- Attend RACP interview
- Receive RACP comparability decision (substantially or partially comparable)
- Secure job offer — Local Health Network, private cancer service, or regional centre
- Apply for AHPRA limited or specialist registration via MedBA
- Complete chemotherapy credentialling at the appointing hospital
- Lodge visa — typically 482 with 186 pathway, or 491 for regional placement
- Complete RACP peer review or supervised practice and apply for permanent residency
Frequently Asked Questions
Is medical oncology on the Accelerated Specialist Pathway?
No. The Accelerated Specialist Pathway is currently restricted to Cardiology, Paediatric Cardiology, Gastroenterology, Geriatric Medicine, Nephrology, and Adult Rehabilitation Medicine. Medical oncologists must use the Standard Specialist Assessment Pathway, which takes 4-6 months from application to comparability decision.
Can I work as a senior medical oncology registrar while RACP assessment is in progress?
Yes. Many overseas-trained medical oncologists arrive on a 482 in a senior registrar, oncology fellow, or medical officer role under AHPRA general or limited registration. The clinical work counts toward Australian experience and is often supervised by the same consultants who will later support the RACP comparability process.
Is haematology a separate ANZSCO code?
Yes. Haematologist is ANZSCO 253918, distinct from Medical Oncologist 253314. Applicants whose practice spans both should choose the code that best matches their current full-time clinical work. RACP advanced training in haematology is a separate program from medical oncology.
What additional registration do I need to prescribe chemotherapy?
AHPRA specialist (or limited) registration is the legal prerequisite. Each appointing hospital then runs an internal chemotherapy credentialling process — reviewing prescribing experience, exposure to specific regimens, and competency in managing toxicities. This is administrative rather than examinable but is a hard requirement before the first prescription.
Which Australian state has the strongest medical oncology workforce demand in 2026?
Queensland and South Australia show the most explicit overseas recruitment in 2026, particularly for regional cancer services. NSW remains the largest single market by volume but is the most competitive. Victoria's Peter MacCallum and major Melbourne services recruit globally but with high competition.
Do I need separate registration to participate in clinical trials?
No additional AHPRA registration is required, but Good Clinical Practice (GCP) certification is universally expected. Most cancer services require evidence of GCP training and Therapeutic Goods Administration (TGA) familiarity before trial work begins. Both are short courses, not exams.
